View Full Version : General Cancer News
- Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new c
- Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial
- Karolinska Institutet receives donation to advance breast cancer research
- Autologous stem cell transplantation may benefit breast cancer patients
- Extended treatment with active ingredient increases bone volume and calcium content
- FBR releases new PSA, Jen's Story 2
- Breast cancer organizations form new agreement to raise funds for research
- Oh my...say it aint so.
- Results from Bionovo's phase 1B clinical trial of Bezielle published
- New research shows cutting tobacco smoking reduces cancer deaths in Europe
- Canadian Breast Cancer Foundation supports unique event for breast cancer awareness
- Environmental health groups call for ban on BPA from all food applications
- Space technology can now be used for detecting cancer tumours
- Study results show increase of mortality due to colon cancer in Spain
- Medical professionals and breast cancer survivors to attend 10th international confer
- Breast cancer and ovarian cancer tests not appropriate for all women, say experts
- Unique partnership leverages funds and technology to track and improve breast screeni
- Preventing two oestrogen influencing receptors from 'conversing' may prevent breast c
- Multi-lingual breast health booklet introduced for underserved population of women in
- More than half of women with DCIS are spared a mastectomy
- I'm new
- Social factors still influence access to cancer services
- Researchers propose a new model for breast cell differentiation
- Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials
- European Breast Cancer Conference in Barcelona, Spain
- Ericson Manufacturing supports breast cancer research and community outreach projects
- Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study
- New heating therapy reduces mastectomies, kills large tumors
- First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast
- Stem Cell Assurance performs first regenerative cell breast augmentation surgery
- Medco Health Solutions launches Medco TRC for oncology patients
- Genomic Health announces global commercial availability of its Oncotype DX colon canc
- Data demonstrates overall radiation with digital mammography is less than film mammog
- Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tab
- Quitting smoking doubles survival chances in lung cancer patients
- New sensor could help diagnose and treat a variety of diseases
- Report on Romania's pharmaceuticals and healthcare industry
- AKD Global announces new class of cancer treatments in development
- The American Journal of Pathology: Highlights from February 2010 issue
- Hi This is my first message
- Hi This is my first post
- Conflict of interest at Baylor
- Researchers identify new gene signature that predicts cancer recurrence in certain br
- Long-term graft retention is improved through supplementation of fat grafts with ADRC
- ZIOPHARM receives Notice of Allowance for palifosfamide from U.S. patent office
- Findings may yield novel therapeutic strategies for late-stage breast cancer
- Case Western Reserve University School of Medicine awarded 6 DOD CDMRP grants for med
- Regular exercise and drinking tea may reduce depression in breast cancer patients
- Transdermal estrogen therapies: Effective alternatives to oral estrogen and compounde
- Pfizer's new pipeline shows growth and diversity in research and development
- Formatech donates $308K in aseptic liquid fill and finish manufacturing services
- Celgene reports total revenue of $758M for fourth-quarter of 2009
- Most Britons not aware of the dangers of alcohol misuse
- Baylor Sammons Breast Center receives accreditation from NAPBC
- Methodology and evidence behind national mammography guidelines is questionable, says
- Hormones & Cancer: A new journal from The Endocrine Society
- Global market for oncology drugs is forecast to reach $80 billion by 2050
- Johns Hopkins University School of Nursing: Research news
- Port needles recalled
- FDA grants accelerated approval for GlaxoSmithKline's TYKERB
- FDA approves new drug combination for hormone positive and HER2-positive advanced bre
- Cardiologist provides heart-healthy tips for women
- Incidence and prevalence database for over 4,500 diseases and procedures
- KMW's Marni Fund raises nearly $450,000 for breast cancer research
- Ipsen reports consolidated group sales of €1,032.8M for 2009
- Belfast scientists identify gene that can help predict tamoxifen treatment failure
- First Edition: February 1, 2010
- Breast cancer: 1 in 9 women affected, early detection vital
- Scientists find that protease HtrA2 can "clean" cells of oncogene WT1
- NeoMatrix, Novation sign new technology agreement
- Vizioncore makes $500 donation to fight against breast cancer
- Study finds racial, ethnic and socioeconomic disparities in cancer incidence
- Iodoprovidone exhibits safety and efficiency in management of malignant pleural effus
- ACCP and FIRS honor World Cancer Day
- Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer
- USPTO issues three patents to Rosetta Genomics
- American Heart Month aims to spread awareness of women and heart disease
- EuroHOPE study: Performance evaluation of the European healthcare system
- Researchers find low prevalence of tamoxifen use for prevention of breast cancer amon
- Breast cancer: Lower dose of radiotherapy in fewer, larger doses as effective as high
- Getting paid to fill out surveys from cashcrate.com - is it legit?
- Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with b
- Findings point towards new therapeutic approach for breast and prostate cancer
- P4P reimbursement program does not necessarily translate to patients, says RAND study
- Racial disparities continue in U.S. cancer screening practices
- Leading researchers discuss latest breakthroughs and best forms of cancer prevention
- Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy
- Competitive landscape in global breast cancer market
- 365 Tips for Healthy Living
- Research suggests a potential means of circumventing drug resistance in breast cancer
- Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnost
- Breast enhancement surgery: Pros, cons and options
- Breast cancer patients taking antidepressant paroxetine at the same time as tamoxifen
- Monetisierung von Projekten an einem Tag ohne Kosten und spezielle Kenntnisse
- Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer
- Provectus Pharmaceuticals publishes article on novel treatment for metastatic melanom
- DMC recommends Celsion to continue its Phase III ThermoDox clinical trial for primary
- sanofi-aventis reports 2009 fourth-quarter and full-year net earnings
- Celebrity promotes fundraising event fro cancer research
- Shenogen Pharma Group, Chemizon sign drug discovery collaboration agreement
- Decline in breast cancer rates linked to race, ethnicity and economic background
- Biological-based therapies are alternative medicines for women recovering from breast
- IPF added to Social Security's "Compassionate Allowances" program
- Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer
- PAN to provide co-payment assistance for medications to underinsured patients through
- New project to unravel secret lives of cancer cells may help produce new cancer thera
- Private hell of Leicester scientist searching for cancer wonder drug
- Local businesses and Change Your Game! Foundation to rally efforts to benefit breast
- SRC-3 gene sends signal to cell membrane to promote cell motility
- Research roundup: Bundled payments, PTSD incidence, cost of treating immigrants
- New conference to discuss issues surrounding breast cancer to take place at UWE
- Annual Income Tax Check-Off for Breast and Cervical Research campaign launched
- SEGT helpful for breast cancer patients with affective disorders
- Howdy
- New fluorescent probes improve tumor detection in mice
- Postmenopausal women undergoing combination hormone therapy at increased risk of hear
- Study confirms link between mammographic breast density and breast cancer
- Disparities in breast cancer treatment: African-American women diagnosed in later sta
- Researchers discover new strategy to overcome drug resistance in breast cancer
- Phase II clinical trial result of abiraterone drug shows promise for advanced prostat
- Fourth-quarter and full-year 2009 results announced by Celsion
- Media examine fight against counterfeit drugs
- Northern California Cancer Center becomes Cancer Prevention Institute of California
- Researchers develop guidelines for assessment, treatment and management of lymphedema
- Researchers discover new prognosis marker for prostate cancer
- Researcher develops acoustic resonant sensor that can test bodily fluids for variety
- Incyte announces 2009 financial results and key fourth-quarter accomplishments
- Johns Hopkins Medicine acquires Naviscan Positron Emission Mammography for radiotrace
- Medical experts convene to discuss emotional and medical issues of young breast cance
- Scottish scientists identify link between deprivation and breast cancer survival
- The Methodist Hospital Research Institute awarded $11.5M NIH grant for research into
- BioSante Pharmaceuticals' LibiGel clinical update to be presented at 2010 ISSWSH annu
- Health experts explore risk reduction and management strategies for lymphedema
- VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC sh
- Johns Hopkins Kimmel Cancer Center scientists develop genome-based blood tests for ca
- Landmark collaboration to launch largest study of breast cancer in Latin American wom
- Young women diagnosed with breast cancer impacted by issues often not faced by older
- Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PH
- Conference for Young Women Affected by Breast Cancer: 10th anniversary
- Unveil Your Pink: Excitement surrounds upcoming charity fundraiser
- Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in South
- Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date
- Researchers develop new tool to understand how cancer grows
- Greater New York City Affiliate of Susan G. Komen for the Cure commences one-year cel
- RNCRR uses Parascript' AccuDetect CAD software to detect breast cancer
- Ritter Pharmaceuticals to discuss lactose intolerance and associated health risks at
- BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Add
- Combination of MRI and mammography reduces mortality rate in high-risk women
- Unique resource for families facing hereditary breast and ovarian cancer
- Combining PARP inhibitors with existing cancer drugs promising
- Genentech's Avastin combination Phase III study in advanced stomach cancer does not m
- USPSTF mammography recommendations: Avon Foundation for Women survey confirms states
- Menssana Research develops 85% accurate breath test for pulmonary tuberculosis
- Findings suggest bitter melon extract may help in preventing breast cancer
- Natural treatment to help alleviate menopause related symptoms
- Scientists identify key mechanism of drug resistance in breast cancer patients
- USPSTF-recommended guidelines lead to decline in mammograms and early detection progr
- Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endp
- Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric can
- Institute of Medicine to be congratulated for calling more resources to fight hyperte
- Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, br
- Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study
- Signaling molecules may link certain actions of B cells to solid tumor growth: Study
- Lab research targets 'estrogen-receptor positive' breast cancer cells; identifies key
- OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatme
- Scientists identify new way to treat castrate resistant cells in prostate cancer pati
- Genta initiates new dose-ranging study of tesetaxel drug
- Manhattan Scientifics completes agreement to acquire all commercial rights to Senior
- New dietary supplement blocks triggering mechanism causing breast cell mutations
- EVA trial: MRI is more accurate for early diagnosis of breast cancer than digital mam
- CPM procedure may only offer survival benefit to breast cancer patients age 50 and yo
- Massaging advanced cancer patients for 14 minutes can reduce stress: Study
- Nanotechnology to tackle side effects and drug resistance in treatment of cancer
- Integrative oncology program aims to address cancer patients' needs from every angle
- Fragility fractures: 'Own the Bone' program for enhancing prevention and treatment
- Hypnosis may help reduce pain and suffering in metastatic breast cancer patients
- Micrometastases in axillary lymph nodes associated with poorer overall survival in br
- MRI more accurate than digital mammography or ultrasound for early diagnosis of breas
- Looking for High Bandwidth hosting
- Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partner
- Celsion to commence Phase II Study of ThermoDox and RFA for CRLM
- Gene research offers new hope for targeted breast cancer treatment
- AdMeTech Foundation: Health care reform highlights need for better screening and prev
- Foster Friess to make substantial contribution to fund ovarian cancer research at TGe
- Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for preventio
- New class of breast cancer: Overexpression of LRP6 gene could be a potential marker
- Future work may uncover links between insulin use and cancer risk, say researchers
- Combination of two targeted therapies effective against subset of gastric cancers: St
- Study shows cryoablation technique offers a potential treatment for breast cancer
- TechniScan launches clinical study to assess clinical utility of Warm Bath Ultrasound
- Bisphosphonate drugs used to prevent osteoporosis may also help reduce risk of breast
- Findings could lead to new cancer-fighting drugs
- Bisphosphonates may lower risk of breast cancer
- Common diabetes therapies may increase cancer risk, but more research needed
- PINC trial to test anti-malarial drug in women with DCIS
- Starting radiotherapy as soon as possible could minimise breast cancer recurrence
- PCF: PSA screening remains valuable tool for identifying potential prostate disease
- Recurrence of breast cancer in older women: Delaying post-surgical radiation treatmen
- New federal guidelines on breast cancer screening: Stanford experts disagree
- Cryoablation kills breast tumors in mice
- Longer wait for radiation treatment after breast cancer surgery increases risk of rec
- Celldex Therapeutics reports net loss of $13.5M for fourth-quarter of 2009
- DVT Awareness In Motion: Educational program on the importance of preventative care f
- New Test Tells if Cancer Has Come Back
- Accurate, life-saving diagnostic tools needed for screening and prevention of prostat
- Acupuncture may reduce joint pain and stiffness caused by routine breast cancer thera
- BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes
- Second AACR cancer research conference to be hosted in Dead Sea, Jordan
- bioTheranostics launches CancerTYPE ID database and KRAS mutational testing
- Life Technologies, TGen, US Oncology collaborate to sequence genomes of triple negati
- University of Delaware psychology student wins NIH Ruth L. Kirschstein National Resea
- Presentation of results from open-label extension study of Xenazine announced
- Breast cancer patients with early stage disease may not benefit from radiation after
- Improvements needed in communicating cancer recurrence risks and treatment decisions
- Sigma Life Science extends portfolio of knockout rat models with the release of ADME/
- Positive Phase 2 data from Nektar Therapeutics' NKTR-102 study in women with platinum
- iCAD granted patent covering SecondLook Digital CAD solution incorporating lesion met
- Sanofi's Latest Challenge: Women Who Say Its Chemotherapy Left Them Permanently Bald
- Positive results from international study of Oncotype DX breast cancer RS published
- Corning Lab for Cure program
- Elderly women over 70 have higher prevalence of cancer detected in second breast by M
- Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detect
- TechniScan commences study with WBU system for automated breast ultrasound imaging
- Researchers identify a new mechanism for tumor control
- Celebrity supports fundraising event for cancer research
- Side-Out Foundation sponsors new advanced breast cancer clinical trial
- Bilateral oophorectomy may do more harm than good
- Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation
- Exonhit Therapeutics' 2009 consolidated revenues up 16% to € 4.9 million
- Risk-free psychological treatment can be better alternative to drugs in treating wome
- Imaging tools may help address challenging clinical dilemma of prostate cancer care:
- African-Americans and Hispanics are at higher risk for developing Alzheimer's and dem
- Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009
- Iraqi National Cancer Research Program established to curb rising incidence of breast
- Cytokeratins 8 and 18 can strongly enhance breast cancer drug fulvestrant's anti-estr
- ABH to host three events featuring Dermagraft at DF Con 2010
- Canadian Breast Cancer Foundation Music Downloads store launched
- ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical
- Peregrine Pharmaceuticals' third-quarter fiscal 2010 total revenues up 45%
- PSA test is still the best option for diagnosing prostate cancer
- TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast canc
- TechniScan utilizes NVIDIA Tesla GPUs in WBU system for diagnostic breast imaging
- Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug
- Two Phase 3 studies of Sutent in advanced breast cancer fail to meet primary endpoint
- Provectus Pharmaceuticals receives $7.5M in private placement offering
- Halozyme Therapeutics reports net loss of $12.7M for fourth-quarter of 2009
- Researchers discover microtentacles that play key role in spreading cancer to distant
- Christiana Care Breast Center nurse awarded 2010 Pearl Moore Making a Difference Awar
- Reducing collateral damage to excised tissue: Surgeons study device using radiofreque
- BioSante Pharmaceuticals receives receipt of Orphan Drug designation for GVAX Pancrea
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.